Jiangsu Cancer Institute & Hospital

This study tests a new drug combination for people with a specific, high-risk type of ovarian cancer that has not yet been treated. The treatment includes a targeted drug (disitamab vedotin) plus standard chemotherapy and a blood-vessel blocker (bevacizumab). After initial treatm…

This study tests a combination of two immune-boosting drugs (iparomlimab and tuvonralimab) plus chemotherapy for people with stage III non-small cell lung cancer that cannot be surgically removed. The goal is to see if this treatment shrinks tumors enough to allow surgery or impr…

This study tests a combination of an oral chemotherapy drug (paclitaxel) and radiation therapy for people with advanced esophageal cancer that cannot be removed by surgery. The trial includes 22 participants aged 70 or older, or those who cannot tolerate standard IV chemo. The go…